相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Genomic Diversification, Structural Plasticity, and Hybridization in Leishmania (Viannia) braziliensis
Luz H. Patino et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Serine Proteinases in Leishmania (Viannia) braziliensis Promastigotes Have Distinct Subcellular Distributions and Expression
Raquel Santos-de-Souza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Leishmanicidal therapy targeted to parasite proteases
Patricia de Almeida Machado et al.
LIFE SCIENCES (2019)
Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56/ARM58 transcripts and reduced drug uptake
Jeronimo Nunes Rugani et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2019)
Calpains of Leishmania braziliensis: genome analysis, differential expression, and functional analysis
Vitor Ennes-Vidal et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2019)
Understanding serine proteases implications on Leishmania spp lifecycle
Carlos Roberto Alves et al.
EXPERIMENTAL PARASITOLOGY (2018)
Evidence of Subpopulations with Distinct Biological Features Within a Leishmania (Viannia) braziliensis Strain
Lea Cysne-Finkelstein et al.
PROTIST (2018)
Favorable responses to treatment with 5 mg Sbv/kg/day meglumine antimoniate in patients with American tegumentary leishmaniasis acquired in different Brazilian regions
Jamyra Iglesias Cataldo et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2018)
Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)
Lucia Regina Brahim et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2017)
Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil
Mauricio Naoto Saheki et al.
PLOS ONE (2017)
Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study
Thalita Gagini et al.
PARASITE (2017)
Increasing in cysteine proteinase B expression and enzymatic activity during in vitro differentiation of Leishmania (Viannia) braziliensis: First evidence of modulation during morphological transition
Cinthia Bernardes Gomes et al.
BIOCHIMIE (2017)
A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies
Mohammad Akhoundi et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
In Vitro Sensitivity of Paired Leishmania (Viannia) braziliensis Samples Isolated before Meglumine Antimoniate Treatment and after Treatment Failure or Reactivation of Cutaneous Leishmaniasis
Cibele Baptista et al.
DISEASE MARKERS (2015)
Phosphoproteomic analysis of wild-type and antimony-resistant Leishmania braziliensis lines by 2D-DIGE technology
Douglas de Souza Moreira et al.
PROTEOMICS (2015)
Estado actual y futuro de la terapia anti-leishmaniásica en Colombia
Jaime Soto et al.
Biomedica (2014)
Proteinase Inhibitors: A Promising Drug Class for Treating Leishmaniasis
Bernardo Acacio Santini Pereira et al.
CURRENT DRUG TARGETS (2014)
Induction of a Stringent Metabolic Response in Intracellular Stages of Leishmania mexicana Leads to Increased Dependence on Mitochondrial Metabolism
Eleanor C. Saunders et al.
PLOS PATHOGENS (2014)
Comparative proteomic analysis of antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum chagasi lines
Fabiana S. V. Matrangolo et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2013)
Purification, characterization and identification of a senescence related serine protease in dark-induced senescent wheat leaves
Renxian Wang et al.
PHYTOCHEMISTRY (2013)
The Mating Competence of Geographically Diverse Leishmania major Strains in Their Natural and Unnatural Sand Fly Vectors
Ehud Inbar et al.
PLOS GENETICS (2013)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony
V. Adaui et al.
PARASITOLOGY (2011)
Characterization of Leishmania (Leishmania) tropica axenic amastigotes
Abedelmajeed Nasereddin et al.
ACTA TROPICA (2010)
Leishmania Subtilisin Is a Maturase for the Trypanothione Reductase System and Contributes to Disease Pathology
Ryan K. Swenerton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates
Susan Wyllie et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2010)
Serine protease activities in Leishmania (Leishmania) chagasi promastigotes
Raquel Elisa da Silva-Lopez et al.
PARASITOLOGY RESEARCH (2010)
Demonstration of Genetic Exchange During Cyclical Development of Leishmania in the Sand Fly Vector
Natalia S. Akopyants et al.
SCIENCE (2009)
Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials
Susan Wyllie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Rapid fluorescent assay for screening drugs on Leishmania amastigotes
Orly Shimony et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2008)
Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (Glucantime) is higher than that of other Leishmania species and correlates with response to therapy in american tegumentary leishmaniasis
Rilza B. Gayoso Azeredo-Coutinho et al.
JOURNAL OF PARASITOLOGY (2007)
Cutaneous leishmaniasis
Richard Reithinger et al.
LANCET INFECTIOUS DISEASES (2007)
Resistance to antimony and treatment failure in human Leishmania (Viannia) infection
R Rojas et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Factors associated with treatmet failure of cutaneous leishmaniasis with meglumine antimoniate
AM Rodrigues et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2006)
Leishmania amazonensis: early proteinase activities during promastigote-amastigote differentiation in vitro
CR Alves et al.
EXPERIMENTAL PARASITOLOGY (2005)
Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani
S Wyllie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug Pentostam
Y Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Aminoethyl benzenesulfonyl fluoride and its hexapeptide (Ac-VFRSLK) conjugate are both in vitro inhibitors of subtilisin kexin isozyme-1
S Basak et al.
FEBS LETTERS (2004)
Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1
H Denton et al.
BIOCHEMICAL JOURNAL (2004)
Leishmania (Leishmania) amazonensis:: purification and characterization of a promastigote serine protease
RE da Silva-Lopez et al.
EXPERIMENTAL PARASITOLOGY (2004)
Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis
A Schriefer et al.
INFECTION AND IMMUNITY (2004)
Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites
C Brochu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Thiol-induced reduction of antimony(V) into antimony(III):: A comparative study with trypanothione, cysteinyl-glycine, cysteine and glutathione
CD Ferreira et al.
BIOMETALS (2003)
Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione
SC Yan et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2003)
Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil
E Cupolillo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate
F Frézard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Leishmania infantum:: Stage-specific activity of pentavalent antimony related with the assay conditions
J Carrió et al.
EXPERIMENTAL PARASITOLOGY (2000)